IWM Stock UPDATES Russell 2000 ETF (IWM) 115.21 08/24/2014 2

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Russell 2000 ETF (IWM) 115.21 $IWM

Stocks to Buy at All-Time Highs - Investment Ideas
David Bartosiak - Zacks Investment Research - Thu Aug 21, 1:38PM CDT
Stocks to Buy at All-Time Highs - Investment Ideas

'Fast Money' Recap: Forget the Fed, What About Apple?
at The Street - Thu Aug 21, 4:00AM CDT
The trading panel discussed Apple's performance and what it needs to do to move the stock higher.

Nasdaq Composite: What Are You Buying That's Driving New Highs? - Real Time Insight
Zacks Equity Research - ZACKS - Mon Aug 18, 1:04PM CDT
It's not just the big caps attracting all the money

How to Trade the Bounce With Limited Downside Risk
at The Street - Tue Aug 12, 2:29PM CDT
There is still life left in this bull market. Trade the previous market sector leader for near-term profits. Take a look at ProShares Ultra Russell 2000 ETF.

S&P 500 Headed to 200-Day MA? - Real Time Insight
Kevin Cook - ZACKS - Tue Aug 12, 9:48AM CDT
The bounce is muted so far, but it sounds like sellers waiting in the wings

iShares Russell 2000 Breaks Above 200-Day Moving Average - Bullish for IWM
ETFChannel.com - Mon Aug 11, 3:03PM CDT
In trading on Monday, shares of the iShares Russell 2000 ETF crossed above their 200 day moving average of $113.70, changing hands as high as $114.22 per share. iShares Russell 2000 shares are currently trading up about 1% on the day.

4 Small Cap Stocks That Top Mutual Funds Favor
at Investor's Business Daily - Thu Aug 07, 4:39PM CDT
Small-cap stocks are in the doghouse of the stock market these days. The iShares Russell 2000 Index (IWM) has lagged the S&P 500 for three straight quarters. The market tilt toward large caps has brought small-cap valuations down -- although not to...

Compass Launches Small Cap Low Volatility ETF - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Aug 06, 7:00AM CDT
Investors might be able to find their way with this new small cap ETF from Compass.

Mutual Funds: 3 Corners Of Stock Market Led July Dip
at Investor's Business Daily - Tue Aug 05, 5:30PM CDT
Mutual fund investors may cringe when they open their July statements, especially if they were invested in the hardest-hit corners of the global market: small-caps, utilities and Europe. High valuations, worries over the Federal Reserve raising...

Declining Utility Stocks Signal Gains Ahead for Russell 2000
at The Street - Tue Aug 05, 12:10PM CDT
The recent shift of funds from utility stocks to the Russell 2000 index may signal a stronger risk appetite for U.S. equities.

S&P 500 Oversold Bounce Is Right on Schedule, but We're Not Out of the Woods Yet
at The Street - Mon Aug 04, 3:40PM CDT
The S&P 500, Nasdaq and Russell 2000 had a decent bounce today right on schedule, after being very oversold and seeing a doji bar print Friday.

U.S. Equities Took a Beating But Keep on Ticking
at The Street - Mon Aug 04, 1:05PM CDT
Although U.S. equities experienced strong selling pressure last week, upcoming support levels and improved economic data mean confidence could return.

Jobs Growth Steady As She Goes - Real Time Insight
Kevin Cook - ZACKS - Fri Aug 01, 8:36AM CDT
Same story, different month: not too hot, not too cold

'Fast Money' Recap: Falling Markets and Employment Data
at The Street - Fri Aug 01, 4:00AM CDT
The trading panel looked at the drop in the stock market, Friday's employment data and whether to buy Tesla, GoPro or Expedia.

iShares Russell 2000 Index Fund Set to Possibly Rebound After Yesterday's Selloff of 2.28%
Comtex SmarTrend(R) - Thu Jul 31, 4:09PM CDT
iShares Russell 2000 Index Fund (AMEX:IWM) traded in a range yesterday that spanned from a low of $111.05 to a high of $112.99. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $112.23 on volume of 59.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading